Septerna, Common Stock Stock Today

SEPN Stock   5.92  0.23  3.74%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Septerna, Common is selling at 5.92 as of the 22nd of March 2025; that is 3.74 percent decrease since the beginning of the trading day. The stock's open price was 6.15. Septerna, Common has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
IPO Date
25th of October 2024
Category
Healthcare
Septerna, Common is entity of United States. It is traded as Stock on NASDAQ exchange. More on Septerna, Common Stock

Moving together with Septerna, Stock

  0.86MBIO Mustang BioPairCorr
  0.65MBRX Moleculin BiotechPairCorr
  0.79MCRB Seres TherapeuticsPairCorr

Moving against Septerna, Stock

  0.9VALN Valneva SE ADRPairCorr
  0.82DOMH Dominari HoldingsPairCorr
  0.72MDCX Medicus Pharma Downward RallyPairCorr
  0.68MGTX MeiraGTx Holdings PLCPairCorr
  0.58EQ EquilliumPairCorr
  0.56MDGL Madrigal PharmaceuticalsPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Septerna, Stock Highlights

Business ConcentrationPharmaceutical Products, Biotechnology, Healthcare, NASDAQ Composite, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover9.0E-40.001
Fairly Down
Slightly volatile
Total Current Liabilities6.9 MM
Fairly Down
Slightly volatile
Non Current Liabilities Total130.4 M186.7 M
Way Down
Slightly volatile
Total Assets91.8 M150.5 M
Way Down
Slightly volatile
Total Current Assets79.5 M129.6 M
Way Down
Slightly volatile
Septerna, Common can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Septerna, Common's financial leverage. It provides some insight into what part of Septerna, Common's total assets is financed by creditors.
Septerna, Common Stock (SEPN) is traded on NASDAQ Exchange in USA. It is located in 250 East Grand Avenue, South San Francisco, CA, United States, 94080 and employs 73 people. Septerna, Common is listed under Pharmaceutical Products category by Fama And French industry classification. The company conducts business under Healthcare sector and is part of Biotechnology industry. Septerna, Common generates negative cash flow from operations
Check Septerna, Common Probability Of Bankruptcy

Septerna, Common Historical Income Statement

View More Fundamentals

Septerna, Stock Against Markets

Septerna, Common Corporate Management

Daniel DPHILSenior DiscoveryProfile
MS MBAChief OfficerProfile
Uwe KleinSenior SciencesProfile
Richard HansenVice TechnologyProfile
David MartinSenior SciencesProfile
When determining whether Septerna, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Septerna, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Septerna, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Septerna, Common Stock Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Septerna, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Septerna, Common. If investors know Septerna, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Septerna, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Septerna, Common Stock is measured differently than its book value, which is the value of Septerna, that is recorded on the company's balance sheet. Investors also form their own opinion of Septerna, Common's value that differs from its market value or its book value, called intrinsic value, which is Septerna, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Septerna, Common's market value can be influenced by many factors that don't directly affect Septerna, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Septerna, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Septerna, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Septerna, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.